{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:29:11Z","timestamp":1790710151569,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DST New Delhi","award":["SR\/NM\/NS-1162\/2015"],"award-info":[{"award-number":["SR\/NM\/NS-1162\/2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s13346-022-01259-7","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T01:10:40Z","timestamp":1669165840000},"page":"883-913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Precision engineering designed phospholipid-tagged pamidronate complex functionalized SNEDDS for the treatment of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Pavitra","family":"Solanki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd. Danish","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd. Iqbal","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan J.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"1259_CR1","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83:1032\u201345.","journal-title":"Mayo Clin Proc"},{"key":"1259_CR2","doi-asserted-by":"publisher","unstructured":"Sun X, Wei J, Lyu J, Bian T, Liu Z, Huang J, et al. Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis. J Nanobiotechnology BioMed Central. 2019;17:1\u201316. Available from: https:\/\/doi.org\/10.1186\/s12951-019-0447-5","DOI":"10.1186\/s12951-019-0447-5"},{"key":"1259_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00198-009-0844-y","volume":"20","author":"T Peasgood","year":"2009","unstructured":"Peasgood T, Herrmann K, Kanis JA, Brazier JE. An updated systematic review of health state utility values for osteoporosis related conditions. Osteoporos Int. 2009;20:853\u201368.","journal-title":"Osteoporos Int"},{"key":"1259_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/PL00022723","volume":"8","author":"DM Eddy","year":"1998","unstructured":"Eddy DM, Johnston J, Cummings SR, Dawson-Hughes B, Lindsay R, Melton LJ, et al. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report Osteoporos Int. 1998;8:83\u20135.","journal-title":"Status report Osteoporos Int"},{"key":"1259_CR5","doi-asserted-by":"crossref","unstructured":"Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int. 1998;8 Suppl 4.","DOI":"10.1007\/PL00022723"},{"key":"1259_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1258\/mi.2011.011014","volume":"17","author":"RJ Hollick","year":"2011","unstructured":"Hollick RJ, Reid DM. Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties. Menopause Int. 2011;17:66\u201372.","journal-title":"Menopause Int"},{"key":"1259_CR7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.clinthera.2007.08.008","volume":"29","author":"M Pazianas","year":"2007","unstructured":"Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A Review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther. 2007;29:1548\u201358.","journal-title":"Clin Ther"},{"key":"1259_CR8","doi-asserted-by":"publisher","unstructured":"Khajuria DK, Disha C, Vasireddi R, Razdan R, Mahapatra DR. Risedronate\/zinc-hydroxyapatite based nanomedicine for osteoporosis. Mater Sci Eng C. Elsevier B.V.\u00a02016;63:78\u201387. Available from: https:\/\/doi.org\/10.1016\/j.msec.2016.02.062","DOI":"10.1016\/j.msec.2016.02.062"},{"key":"1259_CR9","unstructured":"Maher M. Efficacy and safety of bisphosphonates for. 2014."},{"key":"1259_CR10","doi-asserted-by":"crossref","unstructured":"Widler L, Jaeggi KA, Glatt M, M\u00fcller K, Bachmann R, Bisping M, et al. Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). J Med Chem. 2002;45:3721\u201338.","DOI":"10.1021\/jm020819i"},{"key":"1259_CR11","doi-asserted-by":"crossref","unstructured":"Tissue C. Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). 1983;357\u201361.","DOI":"10.1007\/BF02405058"},{"key":"1259_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF01623454","volume":"7","author":"CF Njeh","year":"1997","unstructured":"Njeh CF, Boivin CM, Langton CM. The role of ultrasound in the assessment of osteoporosis: a review. Osteoporos Int. 1997;7:7\u201322.","journal-title":"Osteoporos Int"},{"key":"1259_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1469-8749.2011.04091.x","volume":"54","author":"D Fehlings","year":"2012","unstructured":"Fehlings D, Switzer L, Agarwal P, Wong C, Sochett E, Stevenson R, et al. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review. Dev Med Child Neurol. 2012;54:106\u201316.","journal-title":"Dev Med Child Neurol"},{"key":"1259_CR14","doi-asserted-by":"publisher","unstructured":"Panzavolta S, Torricelli P, Bracci B, Fini M, Bigi A. Alendronate and pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells. J Inorg Biochem. Elsevier Inc.\u00a02009;103:101\u20136. Available from: https:\/\/doi.org\/10.1016\/j.jinorgbio.2008.09.012","DOI":"10.1016\/j.jinorgbio.2008.09.012"},{"key":"1259_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40364-017-0088-5","volume":"5","author":"TR Kuo","year":"2017","unstructured":"Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res Biomarker Research. 2017;5:5\u201313.","journal-title":"Biomark Res Biomarker Research"},{"key":"1259_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1023\/A:1008626026484","volume":"20","author":"RW Sparidans","year":"1998","unstructured":"Sparidans RW, Twiss IM, Talbot S. Bisphosphonates in bone diseases. Pharm World Sci. 1998;20:206\u201313.","journal-title":"Pharm World Sci"},{"key":"1259_CR17","first-page":"825","volume":"69","author":"SH Ralston","year":"1988","unstructured":"Ralston SH, Alzaid AA, Gallacher SJ, Gardner MD, Cowan RA, Boyle IT. Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia. QJM. 1988;69:825\u201334.","journal-title":"QJM"},{"key":"1259_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1208\/s12249-013-9990-9","volume":"14","author":"NS Desai","year":"2013","unstructured":"Desai NS, Nagarsenker MS. Design and evaluation of self-nanoemulsifying pellets of repaglinide. AAPS PharmSciTech. 2013;14:994\u20131003.","journal-title":"AAPS PharmSciTech"},{"key":"1259_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2009.11.026","volume":"386","author":"J Ruan","year":"2010","unstructured":"Ruan J, Liu J, Zhu D, Gong T, Yang F, Hao X, et al. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int J Pharm. 2010;386:282\u201390.","journal-title":"Int J Pharm"},{"key":"1259_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3109\/10837450.2013.829092","volume":"19","author":"P Niamprem","year":"2014","unstructured":"Niamprem P, Rujivipat S, Tiyaboonchai W. Development and characterization of lutein-loaded SNEDDS for enhanced absorption in Caco-2 cells. Pharm Dev Technol. 2014;19:735\u201342.","journal-title":"Pharm Dev Technol"},{"key":"1259_CR21","first-page":"1","volume":"55","author":"J Baloch","year":"2019","unstructured":"Baloch J, Sohail MF, Sarwar HS, Kiani MH, Khan GM, Jahan S, et al. Self-nanoemulsifying drug delivery system (Snedds) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Med. 2019;55:1\u201313.","journal-title":"Med"},{"key":"1259_CR22","doi-asserted-by":"publisher","unstructured":"Mustapha O, Kim KS, Shafique S, Kim DS, Jin SG, Seo YG, et al. Development of novel cilostazol\u2013loaded solid SNEDDS using a SPG membrane emulsification technique: physicochemical characterization and in vivo evaluation. Colloids Surfaces B Biointerfaces. Elsevier B.V.\u00a02017;150:216\u201322. Available from: https:\/\/doi.org\/10.1016\/j.colsurfb.2016.11.039","DOI":"10.1016\/j.colsurfb.2016.11.039"},{"key":"1259_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1517\/17425247.2014.913566","volume":"11","author":"G Singh","year":"2014","unstructured":"Singh G, Pai RS. Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability: in vitro\/in vivo characterization. Expert Opin Drug Deliv. 2014;11:1023\u201332.","journal-title":"Expert Opin Drug Deliv"},{"key":"1259_CR24","unstructured":"Solanki P, Singh R, Singh VD. Formulation and evaluation of fast dissolving tablet: a review. Solanki al World J Pharm Res. 2016;5."},{"key":"1259_CR25","doi-asserted-by":"publisher","unstructured":"Ma H, Chen H, Sun L, Tong L, Zhang T. Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia. Elsevier B.V.\u00a02014;93:54\u201361. Available from: https:\/\/doi.org\/10.1016\/j.fitote.2013.10.016","DOI":"10.1016\/j.fitote.2013.10.016"},{"key":"1259_CR26","doi-asserted-by":"crossref","unstructured":"Tiwari R, Kumar A, Solanki P, Dhobi M, Sundaresan V, Kalaiselvan V, et al. Analytical quality-by-design (AQbD) guided development of a robust HPLC method for the quantification of plumbagin from Plumbago species. J Liq Chromatogr Relat Technol. 2021.","DOI":"10.1080\/10826076.2021.1973027"},{"key":"1259_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","volume":"114","author":"F Cui","year":"2006","unstructured":"Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006;114:242\u201350.","journal-title":"J Control Release"},{"key":"1259_CR28","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1517\/17425247.2014.912212","volume":"11","author":"KM Hosny","year":"2014","unstructured":"Hosny KM, Aljaeid BM. Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction. Expert Opin Drug Deliv. 2014;11:1015\u201322.","journal-title":"Expert Opin Drug Deliv"},{"key":"1259_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2478\/acph-2013-0040","volume":"63","author":"K \u010cerpnjak","year":"2013","unstructured":"\u010cerpnjak K, Zvonar A, Ga\u0161perlin M, Vre\u010der F. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm. 2013;63:427\u201345.","journal-title":"Acta Pharm"},{"key":"1259_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2174\/1573413711309020014","volume":"9","author":"F Shakeel","year":"2013","unstructured":"Shakeel F, Haq N, Ali M, Alanazi FK, Alsarra IA. Impact of viscosity and refractive index on droplet size and zeta potential of model O\/W and W\/O nanoemulsion. Curr Nanosci. 2013;9:248\u201353.","journal-title":"Curr Nanosci"},{"key":"1259_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/bmc.298","volume":"18","author":"JA Wong","year":"2004","unstructured":"Wong JA, Renton KW, Crocker JFS, O\u2019Regan PA, Acott PD. Determination of pamidronate in human whole blood and urine by reversed-phase HPLC with fluorescence detection. Biomed Chromatogr. 2004;18:98\u2013101.","journal-title":"Biomed Chromatogr"},{"key":"1259_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00228-001-0411-8","volume":"57","author":"S Cremers","year":"2002","unstructured":"Cremers S, Sparidans R, Den Hartigh J, Hamdy N, Vermeij P, Papapoulos S. A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis. Eur J Clin Pharmacol. 2002;57:883\u201390.","journal-title":"Eur J Clin Pharmacol"},{"key":"1259_CR33","first-page":"87","volume":"3","author":"P Bhandare","year":"2010","unstructured":"Bhandare P, Rao BM, Madhavan P, Someswararao N. A validated stability-indicating method for the determination of related substances and assay of pamidronate sodium pentahydrate by hplc without derivatization. Rasayan J Chem. 2010;3:87\u201393.","journal-title":"Rasayan J Chem"},{"key":"1259_CR34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1590\/S0482-50042012000300016","volume":"52","author":"DK Khajuria","year":"2012","unstructured":"Khajuria DK, Razdan R, Mahapatra DR. Description of a new method of ovariectomy in female rats. Rev Bras Reumatol. 2012;52:462\u201370.","journal-title":"Rev Bras Reumatol"},{"key":"1259_CR35","first-page":"424","volume":"58","author":"PP Lelovas","year":"2008","unstructured":"Lelovas PP, Xanthos TT, Thorma SE, Lyritis GP, Dontas IA. The laboratory rat as an animal model for osteoporosis research. Comp Med. 2008;58:424\u201330.","journal-title":"Comp Med"},{"key":"1259_CR36","doi-asserted-by":"crossref","unstructured":"Hayatullina Z, Muhammad N, Mohamed N, Soelaiman I. Virgin Coconut Oil Supplementation Prevents Bone Loss in Osteoporosis Rat Model. 2012;2012.","DOI":"10.1155\/2012\/237236"},{"key":"1259_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s001980050161","volume":"9","author":"JP Bonjour","year":"1999","unstructured":"Bonjour JP, Ammann P, Rizzoli R. Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines. Osteoporos Int. 1999;9:379\u201393.","journal-title":"Osteoporos Int"},{"key":"1259_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/bph.12434","volume":"171","author":"V Vijayan","year":"2014","unstructured":"Vijayan V, Khandelwal M, Manglani K, Gupta S, Surolia A. Methionine down-regulates TLR4\/MyD88\/NF-\u03baB signalling in osteoclast precursors to reduce bone loss during osteoporosis. Br J Pharmacol. 2014;171:107\u201321.","journal-title":"Br J Pharmacol"},{"key":"1259_CR39","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2217\/nnm-2020-0079","volume":"15","author":"F Zakir","year":"2020","unstructured":"Zakir F, Ahmad A, Farooq U, Mirza MA, Tripathi A, Singh D, et al. Design and development of a commercially viable in situ nanoemulgel for the treatment of postmenopausal osteoporosis. Nanomedicine. 2020;15:1167\u201387.","journal-title":"Nanomedicine"},{"key":"1259_CR40","doi-asserted-by":"crossref","unstructured":"Solanki P, Ansari MD, Anjali, Khan I, Jahan RN, Nikita, et al. Repurposing pentosan polysulfate sodium as hyaluronic acid linked polyion complex nanoparticles for the management of osteoarthritis: a potential approach. Med Hypotheses. 2021;157.","DOI":"10.1016\/j.mehy.2021.110713"},{"key":"1259_CR41","doi-asserted-by":"publisher","unstructured":"Mukherjee D, Srinivasan B, Anbu J, Azamthulla M, Teja BV, Ramachandra SG, et al. Pamidronate functionalized mucoadhesive compact for treatment of osteoporosis-in vitro and in vivo characterization. J Drug Deliv Sci Technol. Elsevier.\u00a02019;52:915\u201326. Available from: https:\/\/doi.org\/10.1016\/j.jddst.2019.06.001","DOI":"10.1016\/j.jddst.2019.06.001"},{"key":"1259_CR42","doi-asserted-by":"publisher","unstructured":"Shah FA, Ruscs\u00e1k K, Palmquist A. 50 years of scanning electron microscopy of bone\u2014a comprehensive overview of the important discoveries made and insights gained into bone material properties in health, disease, and taphonomy. Bone Res. Springer US.\u00a02019;7:1\u201315. Available from: https:\/\/doi.org\/10.1038\/s41413-019-0053-z","DOI":"10.1038\/s41413-019-0053-z"},{"key":"1259_CR43","doi-asserted-by":"crossref","unstructured":"Papapoulos SE. Bisphosphonates in the management of postmenopausal osteoporosis. Osteoporosis. 2001;631\u201350.","DOI":"10.1016\/B978-012470862-4\/50073-8"},{"key":"1259_CR44","doi-asserted-by":"publisher","unstructured":"Kim KS, Yang ES, Kim DS, Kim DW, Yoo HH, Yong CS, et al. A novel solid self-nanoemulsifying drug delivery system (S-snedds) for improved stability and oral bioavailability of an oily drug, 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol. Drug Deliv. Informa Healthcare USA, Inc.\u00a02017;24:1018\u201325. Available from: https:\/\/doi.org\/10.1080\/10717544.2017.1344335","DOI":"10.1080\/10717544.2017.1344335"},{"key":"1259_CR45","doi-asserted-by":"publisher","unstructured":"Ansari MD, khan I, Solanki P, Pandit J, Jahan RN, Aqil M, et al. Fabrication and optimization of raloxifene loaded spanlastics vesicle for transdermal delivery. J Drug Deliv Sci Technol. Elsevier B.V.\u00a02022;68:103102. Available from: https:\/\/doi.org\/10.1016\/j.jddst.2022.103102","DOI":"10.1016\/j.jddst.2022.103102"},{"key":"1259_CR46","doi-asserted-by":"crossref","unstructured":"Ansari MD, Saifi Z, Pandit J, Khan I, Solanki P, Sultana Y, et al. Spanlastics a novel nanovesicular carrier: its potential application and emerging trends in therapeutic delivery. AAPS PharmSciTech. AAPS PharmSciTech.\u00a02022;23.","DOI":"10.1208\/s12249-022-02217-9"},{"key":"1259_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1208\/s12249-010-9401-4","volume":"11","author":"SB Upadhye","year":"2010","unstructured":"Upadhye SB, Kulkarni SJ, Majumdar S, Avery MA, Gul W, Elsohly MA, et al. Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of \u03949-tetrahydrocannabinol with modified beta-cyclodextrins. AAPS PharmSciTech. 2010;11:509\u201317.","journal-title":"AAPS PharmSciTech"},{"key":"1259_CR48","doi-asserted-by":"publisher","first-page":"11998","DOI":"10.1002\/anie.201304157","volume":"52","author":"JS Renny","year":"2013","unstructured":"Renny JS, Tomasevich LL, Tallmadge EH, Collum DB. Method of continuous variations: applications of job plots to the study of molecular associations in organometallic chemistry. Angew Chemie - Int Ed. 2013;52:11998\u20132013.","journal-title":"Angew Chemie - Int Ed"},{"key":"1259_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/A:1011117412693","volume":"39","author":"K Hirose","year":"2001","unstructured":"Hirose K. A practical guide for the determination of binding constants. J Incl Phenom. 2001;39:193\u2013209.","journal-title":"J Incl Phenom"},{"key":"1259_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1208\/s12248-015-9837-2","volume":"18","author":"SD Saoji","year":"2016","unstructured":"Saoji SD, Raut NA, Dhore PW, Borkar CD, Popielarczyk M, Dave VS. Preparation and evaluation of phospholipid-based complex of standardized Centella extract (SCE) for the enhanced delivery of phytoconstituents. AAPS J. 2016;18:102\u201314.","journal-title":"AAPS J"},{"key":"1259_CR51","doi-asserted-by":"publisher","unstructured":"Ndamase AS, Aderibigbe BA, Sadiku ER, Labuschagne P, Lemmer Y, Ray SS, et al. Synthesis, characterization and in vitro cytotoxicity evaluation of polyamidoamine conjugate containing pamidronate and platinum drug. J Drug Deliv Sci Technol. Elsevier.\u00a02018;43:267\u201373. Available from: https:\/\/doi.org\/10.1016\/j.jddst.2017.10.011","DOI":"10.1016\/j.jddst.2017.10.011"},{"key":"1259_CR52","doi-asserted-by":"publisher","unstructured":"Dora CP, Kushwah V, Katiyar SS, Kumar P, Pillay V, Suresh S, et al. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid. Int J Pharm. Elsevier.\u00a02017;534:1\u201313. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.071","DOI":"10.1016\/j.ijpharm.2017.09.071"},{"key":"1259_CR53","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.4028\/www.scientific.net\/KEM.336-338.1711","volume":"336\u2013338","author":"E Luo","year":"2007","unstructured":"Luo E, Hu J, Li JH, He G, Wei SC, Cui J. Bisphosphonate pamidronate modifying hydroxyapatite bioceramics for hard tissue repair. Key Eng Mater. 2007;336\u2013338:1711\u20134.","journal-title":"Key Eng Mater"},{"key":"1259_CR54","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1089\/ars.2014.6098","volume":"22","author":"CM Spickett","year":"2015","unstructured":"Spickett CM, Pitt AR. Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology. Antioxidants Redox Signal. 2015;22:1646\u201366.","journal-title":"Antioxidants Redox Signal"},{"key":"1259_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijpharm.2016.12.044","volume":"518","author":"RK Khurana","year":"2017","unstructured":"Khurana RK, Bansal AK, Beg S, Burrow AJ, Katare OP, Singh KK, et al. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: systematic development, characterization and evaluation. Int J Pharm. 2017;518:289\u2013306.","journal-title":"Int J Pharm"},{"key":"1259_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1021\/mp300489p","volume":"10","author":"Z Hou","year":"2013","unstructured":"Hou Z, Li Y, Huang Y, Zhou C, Lin J, Wang Y, et al. Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm. 2013;10:90\u2013101.","journal-title":"Mol Pharm"},{"key":"1259_CR57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/chromsci\/45.5.236","volume":"45","author":"C Fernandes","year":"2007","unstructured":"Fernandes C, Leite RS, Lan\u00e7as FM. Rapid determination of bisphosphonates by ion chromatography with indirect UV detection. J Chromatogr Sci. 2007;45:236\u201341.","journal-title":"J Chromatogr Sci"},{"key":"1259_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijpharm.2007.04.009","volume":"341","author":"RB Shah","year":"2007","unstructured":"Shah RB, Zidan AS, Funck T, Tawakkul MA, Nguyenpho A, Khan MA. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm. 2007;341:189\u201394.","journal-title":"Int J Pharm"},{"key":"1259_CR59","doi-asserted-by":"publisher","unstructured":"Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surfaces B Biointerfaces. Elsevier B.V.\u00a02012;100:50\u201361. Available from: https:\/\/doi.org\/10.1016\/j.colsurfb.2012.05.019","DOI":"10.1016\/j.colsurfb.2012.05.019"},{"key":"1259_CR60","doi-asserted-by":"crossref","unstructured":"Nasr A, Gardouh A, Ghorab M. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 2016;8.","DOI":"10.3390\/pharmaceutics8030020"},{"key":"1259_CR61","first-page":"591","volume":"3","author":"DG Fatouros","year":"2007","unstructured":"Fatouros DG, Karpf DM, Nielsen FS, Mullertz A. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag. 2007;3:591\u2013604.","journal-title":"Ther Clin Risk Manag"},{"key":"1259_CR62","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s13346-020-00822-4","volume":"11","author":"DR Telange","year":"2021","unstructured":"Telange DR, Sohail NK, Hemke AT, Kharkar PS, Pethe AM. Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin. Drug Deliv Transl Res. 2021;11:1056\u201383.","journal-title":"Drug Deliv Transl Res"},{"key":"1259_CR63","unstructured":"Telange DR. Drug-phospholipid complex-loaded matrix film formulation for the enhanced transdermal delivery of quercetin how has open access to Fisher Digital Publications benefited you\u202f? Drug-phospholipid complex-loaded matrix film formulation for the enhanced. 2018;31\u201350."},{"key":"1259_CR64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijpharm.2019.01.067","volume":"560","author":"T Moolakkadath","year":"2019","unstructured":"Moolakkadath T, Aqil M, Ahad A, Imam SS, Praveen A, Sultana Y, et al. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice. Int J Pharm. 2019;560:78\u201391.","journal-title":"Int J Pharm"},{"key":"1259_CR65","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3109\/10717544.2013.878003","volume":"22","author":"AW Khan","year":"2015","unstructured":"Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv. 2015;22:552\u201361.","journal-title":"Drug Deliv"},{"key":"1259_CR66","first-page":"1","volume":"2015","author":"AM Nauli","year":"2015","unstructured":"Nauli AM, Whittimore JD. Using caco-2 cells to study lipid transport by the intestine. J Vis Exp. 2015;2015:1\u20138.","journal-title":"J Vis Exp"},{"key":"1259_CR67","doi-asserted-by":"publisher","unstructured":"Khan I, Pandit J, Ahmed S, Zameer S, Nikita, Ahmad S, et al. Development and evaluation of biodegradable polymeric lomustine nanofibres for the efficient tumor targeting: in vitro characterization, ex vivo permeation and degradation study. J Drug Deliv Sci Technol. Elsevier B.V.\u00a02022;75:103685. Available from: https:\/\/doi.org\/10.1016\/j.jddst.2022.103685","DOI":"10.1016\/j.jddst.2022.103685"},{"key":"1259_CR68","doi-asserted-by":"crossref","unstructured":"Solanki P, Sultana Y, Singh S. Traditional medicine: exploring their potential in overcoming multi-drug resistance. Strateg to Overcome Superbug Invasions Emerg Res Oppor. 2021;118\u201329.","DOI":"10.4018\/978-1-7998-0307-2.ch006"},{"key":"1259_CR69","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1080\/17425247.2016.1224845","volume":"13","author":"HA Abo Enin","year":"2016","unstructured":"Abo Enin HA, Abdel-Bar HM. Solid super saturated self-nanoemulsifying drug delivery system (sat-SNEDDS) as a promising alternative to conventional SNEDDS for improvement rosuvastatin calcium oral bioavailability. Expert Opin Drug Deliv. 2016;13:1513\u201321.","journal-title":"Expert Opin Drug Deliv"},{"key":"1259_CR70","doi-asserted-by":"publisher","unstructured":"Ahmed S, Gull A, Alam M, Aqil M, Sultana Y. Ultrasonically tailored, chemically engineered and \u201cQbD\u201d enabled fabrication of agomelatine nanoemulsion; optimization, characterization, ex-vivo permeation and stability study. Ultrason Sonochem. Elsevier.\u00a02018;41:213\u201326. Available from: https:\/\/doi.org\/10.1016\/j.ultsonch.2017.09.042","DOI":"10.1016\/j.ultsonch.2017.09.042"},{"key":"1259_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1590\/S1984-82502012000400020","volume":"48","author":"MA Mirza","year":"2012","unstructured":"Mirza MA, Rahman MA, Talegaonkar S, Iqbal Z. In vitro\/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis. Brazilian J Pharm Sci. 2012;48:759\u201372.","journal-title":"Brazilian J Pharm Sci"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-022-01259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-022-01259-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-022-01259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T01:30:30Z","timestamp":1675474230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-022-01259-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1259"],"URL":"https:\/\/doi.org\/10.1007\/s13346-022-01259-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"7 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I conducted animal studies myself with integrity, fidelity, and honesty. I openly take responsibility for my actions, and only make agreements, which I intend to keep. I did not intentionally engage in or participate in any form of malicious harm to another person or animal. Prior approval was taken from the institutional animal ethical committee for use of female wistar rats.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This research work was approved by Institutional Animal Ethics Committee, Jamia Hamdard, New Delhi wide animal protocol no. 1726.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Author declares that they have provided their consent for publishing this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}